Literature DB >> 16244487

Intravenous TPA for very old stroke patients.

Chin-I Chen1, Yasuyuki Iguchi, James C Grotta, Zsolt Garami, Ken Uchino, Hashem Shaltoni, Andrei V Alexandrov.   

Abstract

BACKGROUND: Although thrombolysis in patients with advanced age is considered more risky, some may benefit from TPA treatment. We studied safety and recanalization/recovery in patients older than 80 years treated with TPA and compared them with younger stroke patients.
METHODS: We studied patients treated with intravenous TPA and divided them into younger (<80 years) and older (> or =80 years) groups for comparison. Diagnostic transcranial Doppler was completed before bolus, and patients were consequently monitored for up to 2 h when feasible. Clinical data included NIH Stroke Scale score, symptomatic intracranial hemorrhage (ICH) and discharge disposition.
RESULTS: We studied 127 younger (mean 63 years, range 31-79) and 56 older patients (mean 84 years, range 80-93). Median baseline NIH Stroke Scale score was higher in the older group (18 vs. 14 points, NS). Occlusion locations, onset to needle time (median 130 vs. 120 min) as well as improvement at 24 h (median 5 vs. 4 points) were similar in both groups. Transcranial Doppler monitoring showed similar partial or complete recanalization rates (66 vs. 66%), onset to recanalization time (median 160 vs. 158 min) and reocclusion rates (26 vs. 25%). Symptomatic and fatal ICH was not higher in the older group (7.1 and 3.5% vs. 6.3 and 3.9%, NS). There was higher mortality among older patients (20 vs. 11%, NS). At discharge, 23% of older patients went home, 41% underwent rehabilitation and 16% were transferred to skilled nursing facilities, compared with 31, 43 and 15% respectively, in the younger group.
CONCLUSION: After intravenous TPA treatment, patients over 80 years of age have similar recanalization, short-term improvement and symptomatic ICH rates compared with younger patients. However, older patients tend to have higher in-hospital mortality. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16244487     DOI: 10.1159/000089086

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  17 in total

1.  Navigating the gray zones of stroke management for a graying population.

Authors:  Meng Lee; Bruce Ovbiagele
Journal:  Cerebrovasc Dis       Date:  2010-03-30       Impact factor: 2.762

Review 2.  Thrombolysis, stroke-unit admission and early rehabilitation in elderly patients.

Authors:  Laurent Derex; Norbert Nighoghossian
Journal:  Nat Rev Neurol       Date:  2009-08-04       Impact factor: 42.937

3.  Safety of thrombolysis in patients over the age of 80.

Authors:  Joshua Zebadiah Willey; Nils Petersen; Mandip S Dhamoon; Joshua Stillman; Bernadette Boden-Albala; Mitchell S V Elkind; Randolph S Marshall
Journal:  Neurologist       Date:  2012-03       Impact factor: 1.398

4.  Analysis of tissue plasminogen activator eligibility by sex in the Greater Cincinnati/Northern Kentucky Stroke Study.

Authors:  Tracy E Madsen; Jane C Khoury; Kathleen A Alwell; Charles J Moomaw; Brett M Kissela; Felipe De Los Rios La Rosa; Daniel Woo; Opeolu Adeoye; Matthew L Flaherty; Pooja Khatri; Simona Ferioli; Dawn Kleindorfer
Journal:  Stroke       Date:  2015-01-27       Impact factor: 7.914

5.  Thrombolytic therapy for acute ischaemic stroke in octogenarians: selection by magnetic resonance imaging improves safety but does not improve outcome.

Authors:  P A Ringleb; Ch Schwark; M Köhrmann; S Külkens; E Jüttler; W Hacke; P D Schellinger
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10-20       Impact factor: 10.154

6.  Safety of protocol violations in acute stroke tPA administration.

Authors:  Michael J Lyerly; Karen C Albright; Amelia K Boehme; Reza Bavarsad Shahripour; James T Houston; Pawan V Rawal; Niren Kapoor; Muhammad Alvi; April Sisson; Anne W Alexandrov; Andrei V Alexandrov
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-08-15       Impact factor: 2.136

7.  Intravenous thrombolysis in acute ischaemic stroke: from trial exclusion criteria to clinical contraindications. An international Delphi study.

Authors:  Maaike Dirks; Louis W Niessen; Peter J Koudstaal; Cees L Franke; Robert J van Oostenbrugge; Diederik W J Dippel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-01       Impact factor: 10.154

8.  [Ischemic stroke in the elderly--analysis of the Austrian Stroke Unit Registry].

Authors:  Milan R Vosko; Franz Gruber; Stefan Schnabl; Gerhard Ransmayr
Journal:  Wien Med Wochenschr       Date:  2008

Review 9.  Safety and efficacy of thrombolysis with intravenous alteplase in older stroke patients.

Authors:  Hakan Sarikaya
Journal:  Drugs Aging       Date:  2013-04       Impact factor: 3.923

10.  The Potential Impact of Maintaining a 3-Hour IV Thrombolysis Window: How Many More Patients can we Safely Treat?

Authors:  Michael J Lyerly; Karen C Albright; Amelia K Boehme; Reza Bavarsad Shahripour; James T Houston; Pawan V Rawal; Niren Kapoor; Muhammad Alvi; April Sisson; Anne W Alexandrov; Andrei V Alexandrov
Journal:  J Neurol Disord Stroke       Date:  2013-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.